Apr 01, 2020 · MBRX: Get the latest Moleculin Biotech stock price and detailed information including MBRX news, historical charts and realtime prices. Moleculin Biotech Inc : MBRX Stock Price Quote at Ally Invest Free current stock price quotes and data for Moleculin Biotech Inc (MBRX). Research news, charts, stock market performance and earnings. The company's preclinical small molecule portfolios focus on the modulation of hard-to-target tumor cell signaling mechanisms and the metabolism of tumors. Moleculin Biotech was founded by Walter V. Klemp MBRX | Stock Snapshot - Fidelity Apr 03, 2020 · Stock quote and company snapshot for MOLECULIN BIOTECH INC (MBRX), including profile, stock chart, recent news and events, analyst opinions, and research reports. MBRX | Stock Snapshot - Fidelity Skip to Main Content. Premarket analyst action - healthcare - Moleculin Biotech ... Dec 20, 2017 · Moleculin Biotech (MBRX) initiated with Buy rating and $8 (373% upside) price target by Roth Capital. Shares up 7% premarket on light volume. Audentes Ther
(MBRX) Company Bio. Moleculin Biotech, Inc., a preclinical and clinical-stage pharmaceutical company, focuses on the development of anti-cancer drug
Moleculin Biotech, Inc. (MBRX) Stock Price, Quote, History ... 1y Target Est 3.33 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. MBRX Moleculin Biotech — Stock Price and Discussion ... Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. Moleculin Biotech, Inc. Common Stock (MBRX) Real-Time ...
See Moleculin Biotech, Inc. (MBRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
Analyst price targets provided by TipRanks. Quick Links. Advanced Charting · After Hours Quote · Analyst Research Moleculin Biotech Stock Price Forecast, MBRX stock price prediction. Price target in 14 days: 0.711 USD. The best long-term & short-term Moleculin Biotech Find the latest Moleculin Biotech, Inc. (MBRX) stock quote, history, news and other vital NasdaqGS - NasdaqGS Real Time Price. 1y Target Est, 3.33
MBRX | Stock Snapshot - Fidelity
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of oncology drug candidates. Its lead drug candidate is Annamycin for the treatment of relapsed or refractory acute myeloid leukemia (AML) and lung-localized tumors. MBRX: Moleculin Biotech Stock Price - Investing.com
MBRX Price Target | Moleculin Biotech Stock Forecast & Ratings
Get the latest Moleculin Biotech, Inc. MBRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Moleculin Biotech, Inc. - MBRX - Stock Price Today - Zacks MBRX is down -3.41% Moleculin Biotech (MBRX) Stock Message Board - InvestorsHub Metabasis Therapeutics (NASDAQ:MBRX) Historical Stock Chart Moleculin Biotech (Nasdaq:MBRX), a preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates, will visit the Nasdaq MarketSite in Times Square to celebrate its initial public offering (IPO). MBRX Stock Quote - Moleculin Biotech, Inc. Common Stock ... Mar 27, 2020 · Stock quote for Moleculin Biotech, Inc. Common Stock Common Stock (MBRX) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. MBRX Moleculin Biotech, Inc. Stock Quote